Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kate Lynette Mahon"'
Autor:
Madeleine Cornelia Strach, Nicole Yeung, Hui-Ming Lin, Nabila Ansari, Cherry Koh, Joo-Shik Shin, James Kench, Lisa Horvath, Kate Lynette Mahon
Publikováno v:
Journal of Clinical Oncology. 41:217-217
217 Background: Appendiceal cancers (AC) are rare, associated with peritoneal metastases, and respond poorly to current systemic treatments. There are limited studies on the characteristics and prognostic impact of infiltrating immune cells within th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::531cc03223ebc8c6a6d24297c0de8d08
https://doi.org/10.1200/jco.2023.41.4_suppl.217
https://doi.org/10.1200/jco.2023.41.4_suppl.217
Autor:
Heidi Fettke, Christine Hauser, Edmond Michael Kwan, Chao Dai, Tiantian Zheng, Amy Wang, Winston Tan, Pan Du, Nicole Ng, Patricia Bukczynska, Siavash Foroughi, Lisa-Jane K. Graham, Lisa Horvath, Kate Lynette Mahon, Shidong Jia, Manish Kohli, Arun Azad
Publikováno v:
Journal of Clinical Oncology. 40:153-153
153 Background: The prognostic significance of DDR alterations in mCRPC remains unclear, with conflicting data from prior reports. Whether DDR alterations are predictive of outcomes with therapeutic agents other than PARP inhibitors in mCRPC is also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02884b25947e038d39e020e7f6518c70
https://doi.org/10.1200/jco.2022.40.6_suppl.153
https://doi.org/10.1200/jco.2022.40.6_suppl.153
Autor:
Blossom Mak, Hui-Ming Lin, Kate Lynette Mahon, Anthony M. Joshua, Martin R. Stockler, Howard Gurney, Francis Parnis, Alison Yan Zhang, Tahlia Scheinberg, Gary Wittert, Lisa Butler, Andrew Hoy, Peter Meikle, Lisa Horvath
Publikováno v:
Journal of Clinical Oncology. 40:154-154
154 Background: Elevated circulating sphingolipids are associated with poorer outcomes across the natural history of prostate cancer (PC), including metastatic relapse in localised PC, earlier androgen deprivation failure in metastatic hormone-sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fb7d88e96745b567e7b037b4eef3a47
https://doi.org/10.1200/jco.2022.40.6_suppl.154
https://doi.org/10.1200/jco.2022.40.6_suppl.154
Autor:
Andrea Knox, Heidi Fettke, Christine Hauser, Patricia Bukczynska, Nicole Ng, Siavash Foroughi, Lisa-Jane K. Graham, Kate Lynette Mahon, Winston Tan, Tiantian Zheng, Chao Dai, Pan Du, Shidong Jia, Lisa Horvath, Manish Kohli, Arun Azad, Edmond Michael Kwan, Amy Wang
Publikováno v:
Journal of Clinical Oncology. 40:150-150
150 Background: With the evolving use of targeted therapies exploiting genomic vulnerabilities in mCRPC, screening patients for sensitizing alterations is of increasing relevance. However, the influence of age on the detection of relevant genomic alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e65636154f765d52f79d055a77b2bc
https://doi.org/10.1200/jco.2022.40.6_suppl.150
https://doi.org/10.1200/jco.2022.40.6_suppl.150